Role of MT-MMPs and MMP-2 in pancreatic cancer progression

V Ellenrieder1, B Alber, U Lacher

  • 1Department of Internal Medicine, University of Ulm, Ulm, Germany.

Insights

Matrix metalloproteinase-2 (MMP-2) activation by membrane-type MMPs (MT-MMPs) is key in pancreatic cancer. MT1-MMP activates MMP-2, promoting tumor invasion and desmoplasia.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Matrix metalloproteinase-2 (MMP-2) activation by membrane-type MMPs (MT-MMPs) is linked to tumor progression.
  • Pancreatic cancer is characterized by tumor cell invasion and a prominent desmoplastic reaction.

Purpose of the Study:

  • To investigate the roles of MMP-2 and its activators (MT1-MMP, MT2-MMP, MT3-MMP) in pancreatic cancer cell invasion.
  • To determine the association between MMP-2, MT-MMPs, and the desmoplastic reaction in pancreatic cancer tissues.

Main Methods:

  • Northern blot analysis to quantify MT-MMP transcript levels in pancreatic cancer, chronic pancreatitis, and healthy pancreas tissues.
  • Correlation analyses to assess relationships between MT1-MMP, MMP-2 expression/activity, and desmoplastic reaction extent.
  • Invasion assays using pancreatic cancer cell lines, with and without the MMP inhibitor Batimastat.

Main Results:

  • MT1-MMP and MT2-MMP transcript levels were elevated in pancreatic cancer tissues compared to controls.
  • MT1-MMP expression correlated significantly with MMP-2 expression and activity in pancreatic tumors.
  • MMP-2 expression and activity were strongly linked to both tumor cell invasion and the desmoplastic reaction.

Conclusions:

  • MT1-MMP plays a role in pancreatic cancer progression through MMP-2 activation.
  • MMP-2 is crucial for pancreatic tumor cell invasion and is associated with the characteristic desmoplastic reaction.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...